U.S. House passes $6.4 billion user fee reauthorization bill

As expected, the U.S. House of Representatives passed the $6.4 billion FDA device and drug industry user fee reauthorization bill Wednesday, MassDevice reports. By voice vote, the bill gained approval with a two-third majority. Last week, the Senate passed its own version of the measure by a vote of 96-to-1. Industry and other supporters of both bills say they strike a good balance between the needs of the agency, industry and patients. But consumer groups had wanted stricter requirements, such as harsher premarket standards. Now, both sides must hash out a final bill and reconcile any differences. Story

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.